Anna Leitgeb
2Patents
0h-index
8Co-inventors
21Inventor score
Filing activity: Dec 19, 2012 → Dec 19, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9480701B2 | Low anticoagulant heparins | Emerging Cross-Sectional Technologies | 0 | Active |
| US9480702B2 | Use of chemically modified heparin derivates in sickle cell disease | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.